Global Monogenetic Disorders Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 03-Oct-2022
No. of pages: 105
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Monogenetic Disorders Testing companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Monogenetic Disorders Testing market. Further, it explains the major drivers and regional dynamics of the global Monogenetic Disorders Testing market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Celera Group

- Abbott

- Thermo Fisher Scientific

- ELITech Group

- Quest

- AutoGenomics

- PerkinElmer

- Roche

- Bio-Rad

- Transgenomic

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Monogenetic Disorders Testing Segment by Type

- Carrier Testing

- Diagnostic Testing

- New-Born Screening

- Predictive & Pre-Symptomatic Testing

- Prenatal Testing

- Others

Monogenetic Disorders Testing Segment by Application

- Hospitals

- Specialized Clinics

- Ambulatory Surgical Centers

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Monogenetic Disorders Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Monogenetic Disorders Testing market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Monogenetic Disorders Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Monogenetic Disorders Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Monogenetic Disorders Testing revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Monogenetic Disorders Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Monogenetic Disorders Testing revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Celera Group, Abbott, Thermo Fisher Scientific, ELITech Group, Quest, AutoGenomics, PerkinElmer, Roche and Bio-Rad, etc.

Global Monogenetic Disorders Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monogenetic Disorders Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Carrier Testing
1.2.3 Diagnostic Testing
1.2.4 New-Born Screening
1.2.5 Predictive & Pre-Symptomatic Testing
1.2.6 Prenatal Testing
1.2.7 Others
1.3 Market by Application
1.3.1 Global Monogenetic Disorders Testing Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Monogenetic Disorders Testing Market Size (2017-2028)
2.2 Monogenetic Disorders Testing Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Monogenetic Disorders Testing Market Size by Region (2017-2022)
2.4 Global Monogenetic Disorders Testing Market Size Forecast by Region (2023-2028)
2.5 Global Top Monogenetic Disorders Testing Countries Ranking by Market Size
3 Monogenetic Disorders Testing Competitive by Company
3.1 Global Monogenetic Disorders Testing Revenue by Players
3.1.1 Global Monogenetic Disorders Testing Revenue by Players (2017-2022)
3.1.2 Global Monogenetic Disorders Testing Market Share by Players (2017-2022)
3.2 Global Monogenetic Disorders Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Monogenetic Disorders Testing Revenue
3.4 Global Monogenetic Disorders Testing Market Concentration Ratio
3.4.1 Global Monogenetic Disorders Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monogenetic Disorders Testing Revenue in 2021
3.5 Global Monogenetic Disorders Testing Key Players Head office and Area Served
3.6 Key Players Monogenetic Disorders Testing Product Solution and Service
3.7 Date of Enter into Monogenetic Disorders Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Monogenetic Disorders Testing Breakdown Data by Type
4.1 Global Monogenetic Disorders Testing Historic Revenue by Type (2017-2022)
4.2 Global Monogenetic Disorders Testing Forecasted Revenue by Type (2023-2028)
5 Global Monogenetic Disorders Testing Breakdown Data by Application
5.1 Global Monogenetic Disorders Testing Historic Market Size by Application (2017-2022)
5.2 Global Monogenetic Disorders Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Monogenetic Disorders Testing Revenue by Company (2020-2022)
6.2 North America Monogenetic Disorders Testing Revenue by Type (2017-2028)
6.3 North America Monogenetic Disorders Testing Revenue by Application (2017-2028)
6.4 North America Monogenetic Disorders Testing Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Monogenetic Disorders Testing Revenue by Company (2020-2022)
7.2 Europe Monogenetic Disorders Testing Revenue by Type (2017-2028)
7.3 Europe Monogenetic Disorders Testing Revenue by Application (2017-2028)
7.4 Europe Monogenetic Disorders Testing Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Monogenetic Disorders Testing Revenue by Company (2020-2022)
8.2 Asia Pacific Monogenetic Disorders Testing Revenue by Type (2017-2028)
8.3 Asia Pacific Monogenetic Disorders Testing Revenue by Application (2017-2028)
8.4 Asia Pacific Monogenetic Disorders Testing Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Monogenetic Disorders Testing Revenue by Company (2020-2022)
9.2 Latin America Monogenetic Disorders Testing Revenue by Type (2017-2028)
9.3 Latin America Monogenetic Disorders Testing Revenue by Application (2017-2028)
9.4 Latin America Monogenetic Disorders Testing Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Monogenetic Disorders Testing Revenue by Company (2020-2022)
10.2 Middle East and Africa Monogenetic Disorders Testing Revenue by Type (2017-2028)
10.3 Middle East and Africa Monogenetic Disorders Testing Revenue by Application (2017-2028)
10.4 Middle East and Africa Monogenetic Disorders Testing Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Celera Group
11.1.1 Celera Group Company Details
11.1.2 Celera Group Business Overview
11.1.3 Celera Group Monogenetic Disorders Testing Products and Services
11.1.4 Celera Group Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.1.5 Celera Group Monogenetic Disorders Testing SWOT Analysis
11.1.6 Celera Group Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Monogenetic Disorders Testing Products and Services
11.2.4 Abbott Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.2.5 Abbott Monogenetic Disorders Testing SWOT Analysis
11.2.6 Abbott Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Monogenetic Disorders Testing Products and Services
11.3.4 Thermo Fisher Scientific Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.3.5 Thermo Fisher Scientific Monogenetic Disorders Testing SWOT Analysis
11.3.6 Thermo Fisher Scientific Recent Developments
11.4 ELITech Group
11.4.1 ELITech Group Company Details
11.4.2 ELITech Group Business Overview
11.4.3 ELITech Group Monogenetic Disorders Testing Products and Services
11.4.4 ELITech Group Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.4.5 ELITech Group Monogenetic Disorders Testing SWOT Analysis
11.4.6 ELITech Group Recent Developments
11.5 Quest
11.5.1 Quest Company Details
11.5.2 Quest Business Overview
11.5.3 Quest Monogenetic Disorders Testing Products and Services
11.5.4 Quest Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.5.5 Quest Monogenetic Disorders Testing SWOT Analysis
11.5.6 Quest Recent Developments
11.6 AutoGenomics
11.6.1 AutoGenomics Company Details
11.6.2 AutoGenomics Business Overview
11.6.3 AutoGenomics Monogenetic Disorders Testing Products and Services
11.6.4 AutoGenomics Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.6.5 AutoGenomics Monogenetic Disorders Testing SWOT Analysis
11.6.6 AutoGenomics Recent Developments
11.7 PerkinElmer
11.7.1 PerkinElmer Company Details
11.7.2 PerkinElmer Business Overview
11.7.3 PerkinElmer Monogenetic Disorders Testing Products and Services
11.7.4 PerkinElmer Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.7.5 PerkinElmer Monogenetic Disorders Testing SWOT Analysis
11.7.6 PerkinElmer Recent Developments
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Monogenetic Disorders Testing Products and Services
11.8.4 Roche Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.8.5 Roche Monogenetic Disorders Testing SWOT Analysis
11.8.6 Roche Recent Developments
11.9 Bio-Rad
11.9.1 Bio-Rad Company Details
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad Monogenetic Disorders Testing Products and Services
11.9.4 Bio-Rad Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.9.5 Bio-Rad Monogenetic Disorders Testing SWOT Analysis
11.9.6 Bio-Rad Recent Developments
11.10 Transgenomic
11.10.1 Transgenomic Company Details
11.10.2 Transgenomic Business Overview
11.10.3 Transgenomic Monogenetic Disorders Testing Products and Services
11.10.4 Transgenomic Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.10.5 Transgenomic Monogenetic Disorders Testing SWOT Analysis
11.10.6 Transgenomic Recent Developments
12 Monogenetic Disorders Testing Market Dynamics
12.1 Monogenetic Disorders Testing Market Trends
12.2 Monogenetic Disorders Testing Market Drivers
12.3 Monogenetic Disorders Testing Market Challenges
12.4 Monogenetic Disorders Testing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Monogenetic Disorders Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Carrier Testing
Table 3. Key Players of Diagnostic Testing
Table 4. Key Players of New-Born Screening
Table 5. Key Players of Predictive & Pre-Symptomatic Testing
Table 6. Key Players of Prenatal Testing
Table 7. Key Players of Others
Table 8. Global Monogenetic Disorders Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Monogenetic Disorders Testing Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 10. Global Monogenetic Disorders Testing Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Monogenetic Disorders Testing Revenue Market Share by Region (2017-2022)
Table 12. Global Monogenetic Disorders Testing Revenue by Players (2017-2022) & (US$ Million)
Table 13. Global Monogenetic Disorders Testing Market Share by Players (2017-2022)
Table 14. Global Top Monogenetic Disorders Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenetic Disorders Testing as of 2021)
Table 15. Ranking of Global Top Monogenetic Disorders Testing Companies by Revenue (US$ Million) in 2021
Table 16. Global 5 Largest Players Market Share by Monogenetic Disorders Testing Revenue (CR5 and HHI) & (2017-2022)
Table 17. Key Players Headquarters and Area Served
Table 18. Key Players Monogenetic Disorders Testing Product Solution and Service
Table 19. Date of Key Manufacturers Enter into Monogenetic Disorders Testing Market
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Monogenetic Disorders Testing Market Size by Type (2017-2022) & (US$ Million)
Table 22. Global Monogenetic Disorders Testing Revenue Market Share by Type (2017-2022)
Table 23. Global Monogenetic Disorders Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 24. Global Monogenetic Disorders Testing Revenue Market Share by Type (2023-2028)
Table 25. Global Monogenetic Disorders Testing Market Size by Application (2017-2022) & (US$ Million)
Table 26. Global Monogenetic Disorders Testing Revenue Market Share by Application (2017-2022)
Table 27. Global Monogenetic Disorders Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 28. Global Monogenetic Disorders Testing Revenue Market Share by Application (2023-2028)
Table 29. North America Monogenetic Disorders Testing Revenue by Company (2020-2022) & (US$ Million)
Table 30. North America Monogenetic Disorders Testing Revenue by Type (2017-2022) & (US$ Million)
Table 31. North America Monogenetic Disorders Testing Revenue by Type (2023-2028) & (US$ Million)
Table 32. North America Monogenetic Disorders Testing Revenue by Application (2017-2022) & (US$ Million)
Table 33. North America Monogenetic Disorders Testing Revenue by Application (2023-2028) & (US$ Million)
Table 34. North America Monogenetic Disorders Testing Revenue by Country (2017-2022) & (US$ Million)
Table 35. North America Monogenetic Disorders Testing Revenue by Country (2023-2028) & (US$ Million)
Table 36. Europe Monogenetic Disorders Testing Revenue by Company (2020-2022) & (US$ Million)
Table 37. Europe Monogenetic Disorders Testing Revenue by Type (2017-2022) & (US$ Million)
Table 38. Europe Monogenetic Disorders Testing Revenue by Type (2023-2028) & (US$ Million)
Table 39. Europe Monogenetic Disorders Testing Revenue by Application (2017-2022) & (US$ Million)
Table 40. Europe Monogenetic Disorders Testing Revenue by Application (2023-2028) & (US$ Million)
Table 41. Europe Monogenetic Disorders Testing Revenue by Country (2017-2022) & (US$ Million)
Table 42. Europe Monogenetic Disorders Testing Revenue by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Monogenetic Disorders Testing Revenue by Company (2020-2022) & (US$ Million)
Table 44. Asia Pacific Monogenetic Disorders Testing Revenue by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Monogenetic Disorders Testing Revenue by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Monogenetic Disorders Testing Revenue by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Monogenetic Disorders Testing Revenue by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Monogenetic Disorders Testing Revenue by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Monogenetic Disorders Testing Revenue by Region (2023-2028) & (US$ Million)
Table 50. Latin America Monogenetic Disorders Testing Revenue by Company (2020-2022) & (US$ Million)
Table 51. Latin America Monogenetic Disorders Testing Revenue by Type (2017-2022) & (US$ Million)
Table 52. Latin America Monogenetic Disorders Testing Revenue by Type (2023-2028) & (US$ Million)
Table 53. Latin America Monogenetic Disorders Testing Revenue by Application (2017-2022) & (US$ Million)
Table 54. Latin America Monogenetic Disorders Testing Revenue by Application (2023-2028) & (US$ Million)
Table 55. Latin America Monogenetic Disorders Testing Revenue by Country (2017-2022) & (US$ Million)
Table 56. Latin America Monogenetic Disorders Testing Revenue by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Monogenetic Disorders Testing Revenue by Company (2020-2022) & (US$ Million)
Table 58. Middle East and Africa Monogenetic Disorders Testing Revenue by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Monogenetic Disorders Testing Revenue by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Monogenetic Disorders Testing Revenue by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Monogenetic Disorders Testing Revenue by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Monogenetic Disorders Testing Revenue by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Monogenetic Disorders Testing Revenue by Country (2023-2028) & (US$ Million)
Table 64. Celera Group Company Details
Table 65. Celera Group Business Overview
Table 66. Celera Group Monogenetic Disorders Testing Product and Services
Table 67. Celera Group Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 68. Celera Group Monogenetic Disorders Testing SWOT Analysis
Table 69. Celera Group Recent Developments
Table 70. Abbott Company Details
Table 71. Abbott Business Overview
Table 72. Abbott Monogenetic Disorders Testing Product and Services
Table 73. Abbott Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 74. Abbott Monogenetic Disorders Testing SWOT Analysis
Table 75. Abbott Recent Developments
Table 76. Thermo Fisher Scientific Company Details
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific Monogenetic Disorders Testing Product and Services
Table 79. Thermo Fisher Scientific Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 80. Thermo Fisher Scientific Monogenetic Disorders Testing SWOT Analysis
Table 81. Thermo Fisher Scientific Recent Developments
Table 82. ELITech Group Company Details
Table 83. ELITech Group Business Overview
Table 84. ELITech Group Monogenetic Disorders Testing Product and Services
Table 85. ELITech Group Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 86. ELITech Group Monogenetic Disorders Testing SWOT Analysis
Table 87. ELITech Group Recent Developments
Table 88. Quest Company Details
Table 89. Quest Business Overview
Table 90. Quest Monogenetic Disorders Testing Product and Services
Table 91. Quest Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 92. Quest Monogenetic Disorders Testing SWOT Analysis
Table 93. Quest Recent Developments
Table 94. AutoGenomics Company Details
Table 95. AutoGenomics Business Overview
Table 96. AutoGenomics Monogenetic Disorders Testing Product and Services
Table 97. AutoGenomics Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 98. AutoGenomics Monogenetic Disorders Testing SWOT Analysis
Table 99. AutoGenomics Recent Developments
Table 100. PerkinElmer Company Details
Table 101. PerkinElmer Business Overview
Table 102. PerkinElmer Monogenetic Disorders Testing Product and Services
Table 103. PerkinElmer Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 104. PerkinElmer Monogenetic Disorders Testing SWOT Analysis
Table 105. PerkinElmer Recent Developments
Table 106. Roche Company Details
Table 107. Roche Business Overview
Table 108. Roche Monogenetic Disorders Testing Product and Services
Table 109. Roche Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 110. Roche Monogenetic Disorders Testing SWOT Analysis
Table 111. Roche Recent Developments
Table 112. Bio-Rad Company Details
Table 113. Bio-Rad Business Overview
Table 114. Bio-Rad Monogenetic Disorders Testing Product and Services
Table 115. Bio-Rad Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 116. Bio-Rad Monogenetic Disorders Testing SWOT Analysis
Table 117. Bio-Rad Recent Developments
Table 118. Transgenomic Company Details
Table 119. Transgenomic Business Overview
Table 120. Transgenomic Monogenetic Disorders Testing Product and Services
Table 121. Transgenomic Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 122. Transgenomic Monogenetic Disorders Testing SWOT Analysis
Table 123. Transgenomic Recent Developments
Table 124. Monogenetic Disorders Testing Market Trends
Table 125. Monogenetic Disorders Testing Market Drivers
Table 126. Monogenetic Disorders Testing Market Challenges
Table 127. Monogenetic Disorders Testing Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monogenetic Disorders Testing Sales Market Share by Type: 2021 VS 2028
Figure 2. Carrier Testing Features
Figure 3. Diagnostic Testing Features
Figure 4. New-Born Screening Features
Figure 5. Predictive & Pre-Symptomatic Testing Features
Figure 6. Prenatal Testing Features
Figure 7. Others Features
Figure 8. Global Monogenetic Disorders Testing Sales Market Share by Application: 2021 VS 2028
Figure 9. Hospitals Case Studies
Figure 10. Specialized Clinics Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Monogenetic Disorders Testing Report Years Considered
Figure 13. Global Monogenetic Disorders Testing Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Monogenetic Disorders Testing Market Size 2017-2028 (US$ Million)
Figure 15. Global Monogenetic Disorders Testing Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Monogenetic Disorders Testing Revenue Market Share by Region in 2017 VS 2022
Figure 17. Global Top 10 Monogenetic Disorders Testing Countries Ranking by Market Size (US$ Million) in 2021
Figure 18. Global Monogenetic Disorders Testing Market Share by Players in 2021
Figure 19. Global Top Monogenetic Disorders Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenetic Disorders Testing as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Monogenetic Disorders Testing Revenue in 2021
Figure 21. North America Monogenetic Disorders Testing Revenue Market Share by Company in 2021
Figure 22. North America Monogenetic Disorders Testing Revenue Market Share by Type (2017-2028)
Figure 23. North America Monogenetic Disorders Testing Revenue Market Share by Application (2017-2028)
Figure 24. North America Monogenetic Disorders Testing Revenue Share by Country (2017-2028)
Figure 25. U.S. Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 26. Canada Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 27. Europe Monogenetic Disorders Testing Revenue Market Share by Company in 2021
Figure 28. Europe Monogenetic Disorders Testing Revenue Market Share by Type (2017-2028)
Figure 29. Europe Monogenetic Disorders Testing Revenue Market Share by Application (2017-2028)
Figure 30. Europe Monogenetic Disorders Testing Revenue Share by Country (2017-2028)
Figure 31. Germany Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 32. France Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 33. U.K. Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 34. Italy Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 35. Russia Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Monogenetic Disorders Testing Revenue Market Share by Company in 2021
Figure 37. Asia Pacific Monogenetic Disorders Testing Revenue Market Share by Type (2017-2028)
Figure 38. Asia Pacific Monogenetic Disorders Testing Revenue Market Share by Application (2017-2028)
Figure 39. Asia Pacific Monogenetic Disorders Testing Revenue Share by Region (2017-2028)
Figure 40. China Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 41. Japan Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 42. South Korea Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 43. India Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 44. Australia Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 45. Taiwan Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 46. Indonesia Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 47. Thailand Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 48. Malaysia Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 49. Philippines Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 50. Vietnam Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 51. Latin America Monogenetic Disorders Testing Revenue Market Share by Company in 2021
Figure 52. Latin America Monogenetic Disorders Testing Revenue Market Share by Type (2017-2028)
Figure 53. Latin America Monogenetic Disorders Testing Revenue Market Share by Application (2017-2028)
Figure 54. Latin America Monogenetic Disorders Testing Revenue Share by Country (2017-2028)
Figure 55. Mexico Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 56. Brazil Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 57. Argentina Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 58. Middle East and Africa Monogenetic Disorders Testing Revenue Market Share by Company in 2021
Figure 59. Middle East and Africa Monogenetic Disorders Testing Revenue Market Share by Type (2017-2028)
Figure 60. Middle East and Africa Monogenetic Disorders Testing Revenue Market Share by Application (2017-2028)
Figure 61. Middle East and Africa Monogenetic Disorders Testing Revenue Share by Country (2017-2028)
Figure 62. Turkey Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 63. Saudi Arabia Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 64. UAE Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 65. Celera Group Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 66. Abbott Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 68. ELITech Group Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 69. Quest Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 70. AutoGenomics Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 71. PerkinElmer Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 72. Roche Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 73. Bio-Rad Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 74. Transgenomic Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs